Up and Coming: Haoyang Li, Ph.D. – An Inspired Vaccine
Haoyang Li, Ph.D., is no stranger to quarantine. He was in high school in China when SARS came knocking. “My
Beating HIV and COVID-19 may depend on tweaking vaccine molecules
LA JOLLA—Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune
Crotty Lab
Shane Crotty,
Ph.D.
Professor
Center for Infectious Disease and Vaccine Research
Shane Crotty, Ph.D., and his team study immunity against infectious diseases. They investigate how the immune system remembers infections and vaccines.
Sette Lab
Alessandro Sette,
Dr.Biol.Sci.
Professor
Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research
Alessandro Sette, Dr. Biol. Sci., defines in chemical terms the specific structures (epitopes) that the immune system recognizes and uses this knowledge to measure and understand immune responses.
LJI Scientists Investigate a Powerful Protein Behind Antibody Development
LA JOLLA, CA—Scientists at the La Jolla Institute for Immunology (LJI) have discovered a potential new way to better fight
LJI Donors Turn Health Crisis Into Mission to Champion Institute’s New Cancer Vaccine
Rebecca and Sandy Shapery embody that transformation, and they hope their inspirational journey will soon help save the lives of
Groundbreaking HIV vaccine design strategy shows promise in proof-of-principle tests
LA JOLLA, CA – A collaborative team of scientists has made a successful proof-of-principle demonstration of an advanced HIV vaccine
Q&A with Alessandro Sette, Dr. Biol. Sci.
Raised in Rome, Italy, in a family of lawyers, Dr. Sette started his science career as a young boy in
Dr. Shane Crotty honored with 2019 Frederick W. Alt Award for New Discoveries in Immunology
LA JOLLA, CA—Shane Crotty, Ph.D., a professor at La Jolla Institute for Immunology, has been selected to receive the 2019
Lassa virus’ soft spot revealed
LA JOLLA, CA—As this year’s Lassa fever outbreak in Nigeria is finally ebbing, the total tally came to more than
La Jolla Institute-led consortium awarded up to $35 million by NIH
LA JOLLA—La Jolla Institute Professor Erica Ollmann Saphire, Ph.D., will lead a five-year global effort totaling up to $35 million
New HIV vaccine strategy “pumps” the immune system
LA JOLLA, CA – A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical